Crown Laboratories Recalls Subpotent Nystatin Cream Tubes
Crown Laboratories is recalling 62,274 tubes of Nystatin Cream because the product failed potency testing at the 9-month interval.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, which is a situation where use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences. The hazard is a lack of efficacy (subpotency) rather than a direct safety risk like toxicity or contamination.
Plain-English summary
Crown Laboratories, Inc. is recalling 62,274 tubes of Nystatin Cream, USP 100,000 units per gram, 30 grams. The product is a prescription-only topical antifungal cream manufactured and distributed by Crown Laboratories in Johnson City, Tennessee. The specific lot affected is Y0378A, with an expiration date of 07/2021, and the National Drug Code (NDC) is 0316-0221-30.
The recall was initiated because the product was found to be subpotent, meaning it was out of specification for assay at the 9-month interval. This indicates that the active ingredient, nystatin, may not be present at the required strength to ensure the drug's effectiveness.
The affected product was distributed nationwide in the United States. Consumers and healthcare providers who have this specific lot of Nystatin Cream should stop using it and contact their healthcare provider or pharmacist for guidance on alternative treatment options.
The recalled product
- Product
- NYSTATIN CREAM (NYSTATIN CREAM)
- Brand
- NYSTATIN CREAM
- Manufacturer
- Crown Laboratories
- Category
- Drug — Topical Antifungal
- Hazard
- Affected units
- 62,274
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot: Y0378A
- EXP 07/2021
UPCs (1)
- 0303160221156
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 2 recalled by Crown Laboratories under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 2 products in this recall →Related recalls
Same brand · NYSTATIN CREAM
- ModerateCrown Laboratories Recalls Nystatin Cream for Subpotent Drug Levels
FDA (Drugs) · 2020-07-01
Same hazard · subpotent drug
See all →- ModerateAccord Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02
- HighAccord Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02
- SevereAccord Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02
- HighAccord Healthcare Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02
- HighAccord Recalls Subpotent Levothyroxine Sodium Tablets Nationwide
FDA (Drugs) · 2026-09-02